Back to Search
Start Over
COVID-19 vaccination and allergen immunotherapy (AIT) - A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)
- Source :
- Allergologie Select
- Publication Year :
- 2021
-
Abstract
- Background Vaccinations against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are intended to induce an immune response to protect against infection/disease. Allergen immunotherapy (AIT) is thought to induce a (different) immune response, e.g., to induce tolerance to allergens. In this position paper we clarify how to use AIT in temporal relation to COVID-19 vaccination. Four SARS-CoV-2 vaccines are currently approved in the EU, and their possible immunological interactions with AIT are described together with practical recommendations for use. Materials and methods Based on the internationally published literature, this position paper provides specific recommendations for the use of AIT in temporal relation to a SARS-CoV-2 vaccination. Results AIT is used in 1) allergic rhinitis, 2) allergic bronchial asthma, 3) insect venom allergy, 4) food allergy (peanut). Conclusion For the continuation of an ongoing AIT, we recommend an interval of 1 week before and after vaccination for subcutaneous immunotherapy (SCIT). For sublingual immunotherapy (SLIT) and oral immunotherapy (OIT), we recommend taking them up to the day before vaccination and a break of 2 - 7 days after vaccination. Initiation of a new SCIT, SLIT, or OIT should be delayed until 1 week after the day of the second vaccination. For SCIT, we generally recommend an interval of ~ 1 week to COVID-19 vaccination.
- Subjects :
- Allergy
Allergen immunotherapy
allergic rhinitis
business.industry
SARS-CoV-2
General Engineering
COVID-19
Disease
asthma
medicine.disease
Vaccination
Immune system
Food allergy
Immunology
medicine
allergen immunotherapy
General Earth and Planetary Sciences
Position paper
Position Paper
business
General Environmental Science
Asthma
Subjects
Details
- ISSN :
- 25128957
- Volume :
- 5
- Database :
- OpenAIRE
- Journal :
- Allergologie select
- Accession number :
- edsair.doi.dedup.....3befb590bb413076dd5717d7f2fad6d7